Le Lézard
Classified in: Health
Subjects: CCA, TDS, FVT

Avantor® to Participate in the J.P. Morgan Healthcare Conference


RADNOR, Pa., Jan. 2, 2020 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission critical products and services to customers in the life sciences and advanced technologies & applied materials industries, announced that Michael Stubblefield, President and Chief Executive Officer, and Tom Szlosek, Executive Vice President, Chief Financial Officer, will participate in the J.P. Morgan Healthcare Conference at the Westin St. Francis Hotel in San Francisco, California. Mr. Stubblefield is scheduled to present on Tuesday, January 14, 2020 at 4:30 p.m. (PT). The live webcast can be accessed on the Investors section of the company's website at www.avantorsciences.com

About Avantor 
Avantor® is a leading global provider of mission critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. We operate in more than 30 countries and deliver an extensive portfolio of products and services. We set science in motion to create a better world.

Media Contact 
Allison Hosak
Senior Vice President, Global Communications
Avantor
+1 610.573.2661
[email protected]

Investor Relations Contact 
Helen O'Donnell
Managing Director
Solebury Trout
+1 203.428.3213
[email protected]

SOURCE Avantor and Financial News


These press releases may also interest you

at 23:00
GenScript, a global leader in life sciences and biotechnology, successfully hosted an Open Day event at its Singapore facility on the 16th of April, welcoming more than 50 representatives from Singapore. This event provided an exclusive look into...

at 23:00
Cybervation, an award-winning global technology and healthcare solutions company, proudly announces that its CEO, Purba Majumder, has been distinguished as one of the 2024 100 Women to KNOW Across America. This award from KNOW Women recognizes...

at 22:33
The report titled "Glycated Albumin Assay Market by Product (Animal Glycated Albumin Assay, Human Glycated Albumin Assay), Application (Prediabetes, Type 1 Diabetes, Type 2 Diabetes), End User - Global Forecast 2024-2030" is now available on...

at 22:03
The report titled "Health & Wellness Food Market by Type (Fresh & Natural, Functional Foods & Beverages, Heat & Eat), Nature (Genetically Modified Organism Food, Non-Genetically Modified Organism Food), Fat Content, Category, Free From Category,...

at 21:27
Hanmi Pharmaceutical (KOSPI: 128940, CEO: Jae-Hyun Park), a leading biopharma company in Korea that focuses on research areas such as oncology, obesity/metabolism, and rare diseases, announced it has entered into a Clinical Trial Collaboration and...

at 19:30
Astellas Pharma Inc....



News published on and distributed by: